INTRODUCTION
Obesity
is one of the most critical health problems we face today.
It is a chronic medical condition that affects millions
of Americans, and the problem is growing worse each year.
Obesity is a killer. It causes or contributes to the
development of an array of life-threatening diseases, including
hypertension, heart disease, and type 2 diabetes.
Why
are so many people burdened by the problem of obesity?
Why can't these individuals simply eat less and lose weight?
Unfortunately, the solution to the problem isn't that easy
because the root causes of obesity are a complex interaction
of genetic, social, cultural, and emotional factors.
Unless all aspects of the problem are addressed, it is nearly
impossible for most obese people to achieve sustained weight
loss.
The
OPTIFAST Program offers new hope to the obese. It
is a medically based obesity treatment program that helps
obese patients lose weight safely and maintain their weight
loss. Developed by Sandoz Nutrition (now Novartis
Nutrition), the OPTIFAST Program is based on the belief
that a problem as complex as obesity requires a complex
solutionone that deals effectively with the physical,
social, and emotional aspects of being overweight.
Novartis Nutrition has created a multidisciplinary approach
to obesity treatment that combines a high quality, calorie
controlled liquid diet with behavior modification, nutrition
education, exercise, psychological support, and medical
monitoring of the patient's conditions.
HISTORY
OF THE OPTIFAST PROGRAM
In
the early 1970's, Dr. Victor Vertes, Director of the Department
of Medicine at Mt.
Sinai Hospital
in
Cleveland , OH
, evolved the concept of stimuli narrowing, or using very
controlled liquid nutritional formulas as a means of helping
obese patients lose weight. Dr. Vertes' work grew
out of studies on the physiological effects of this approach
conducted in the late 1960's by Dr. Saul Genuth, Director
of Mt. Sinai's Saltzman Institute for Clinical Investigation.
In
working with obese patients, Drs. Vertes and Genuth discovered
that limiting food intake by using a liquid formula diet
instead effectively promoted rapid weight loss, but that
patients tended to regain the weight once they left the
program. It was clear that another element of treatment
was needed to help patients sustain their weight loss.
In
1974, Sandoz Nutrition developed The OPTIFAST Program with
the assistance of Vertes, Genuth, and other experts in the
treatment of obesity. In addition to the liquid formula
diet, Sandoz Nutrition worked with Dr. Vertes to develop
a weight maintenance program, and with behavior modification
experts from around the country to create the behavioral
system that forms the framework of the present OPTIFAST
Program.
THE
OPTIFAST FORMULA
The
OPTIFAST products are manufactured by Novartis Nutrition
Corporation. Novartis Nutrition has developed a series
of nutritional products useful in the treatment of obesity.
Foremost among them is the OPTIFAST liquid formula, a low-calorie
nutritional product that can be used by patients in a complete
meal replacement program. The OPTIFAST Formula contains
balanced nutrition, including high quality protein, carbohydrates,
minerals, and vitamins. It contains no amphetamines,
laxatives, or water pills, and is available only through
physicians who have received special training in the OPTIFAST
Program treatment.
TESTIMONIALS
If
you are interested in learning more about our program or
would like a free weight management consultation, contact
us by email at inquiries@icnoptifast.com.